ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 26

$601K Total Retail Price of All Prescriptions

Rank: 3 out of 26

374 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 374 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

6% of this provider’s 374 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,900 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 468 405 1 2
SIMVASTATIN 332 266 2 6
FUROSEMIDE 331 280 3 5
AMLODIPINE BESYLATE 306 261 4 1
METFORMIN HCL 259 211 5 18
ATENOLOL 248 238 6 26
WARFARIN SODIUM 242 230 7 7
METOPROLOL TARTRATE 228 193 8 4
LEVOTHYROXINE SODIUM 215 187 9 3
OMEPRAZOLE 212 174 10 8
PRAVASTATIN SODIUM 181 164 11 17
CRESTOR 158 137 12 50
GLIPIZIDE 157 142 13 55
FENTANYL 154 115 S2 14 38
SERTRALINE HCL 149 120 15 15
TRAMADOL HCL 144 131 16 13
PREDNISONE 142 117 17 40
ATORVASTATIN CALCIUM 139 102 18 16
PANTOPRAZOLE SODIUM 125 111 19 23
RANITIDINE HCL 120 103 20 30
MORPHINE SULFATE ER 118 96 S2 21 68
DONEPEZIL HCL 111 99 22 11
POLYETHYLENE GLYCOL 3350 111 111 22 24
METOPROLOL SUCCINATE 107 95 24 22
SPIRIVA 105 83 25 53
POTASSIUM CHLORIDE 104 70 26 31
ALENDRONATE SODIUM 103 100 27 56
ZOLPIDEM TARTRATE 103 75 27 37
OXYCODONE HCL-ACETAMINOPHEN 97 84 S2 29 70
CIPROFLOXACIN HCL 88 75 30 66
HYDROCHLOROTHIAZIDE 84 76 31 20
HYDROCODONE-ACETAMINOPHEN 84 54 S3 31 21
ADVAIR DISKUS 84 77 31 52
LOSARTAN POTASSIUM 83 72 34 39
TRIAMTERENE-HYDROCHLOROTHIAZID 77 69 35 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 71 36 98
ACTOS 74 62 37 99
ALBUTEROL SULFATE 72 71 38 34
ISOSORBIDE MONONITRATE ER 68 68 39 101
MIRTAZAPINE 67 46 40 9
DIGOXIN 66 52 41 50
ESCITALOPRAM OXALATE 65 61 42 47
GABAPENTIN 63 47 43 12
LANTUS 62 55 44 28
CELEBREX 62 48 44 107
LEVOFLOXACIN 58 51 46 58
CYCLOBENZAPRINE HCL 58 35 R 46 112
VESICARE 57 56 48 114
CLOPIDOGREL 56 55 49 36
CYMBALTA 56 41 49 45
NEXIUM 54 41 51 64
TRIAMTERENE-HCTZ 53 52 52 118
DILANTIN 52 18 53 119
ATENOLOL-CHLORTHALIDONE 52 35 53 119
KLOR-CON M20 52 46 53 49
FLUTICASONE PROPIONATE 52 39 53 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.